JFG
MIRM icon

Jefferies Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Jefferies Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,800
Closed -$198K – 1639
2024
Q2 		$198K Sell
5,800
-4,200
-42% -$110K ﹤0.01% 1228
2024
Q1 		$251K Buy
+10,000
New +$275K ﹤0.01% 1271

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group's MIRM Position: Q2 2026 in Review

Jefferies Financial Group increased its Mirum Pharmaceuticals (MIRM) stake by 362% in Q2 2026, buying an estimated $3.09M and bringing the position to 39,260 shares worth $4.6M. The position accounts for 0.03% of the portfolio, ranked #402.

Jefferies Financial Group first reported a position in MIRM in Q1 2024 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Jefferies Financial Group held 39,260 shares of Mirum Pharmaceuticals worth $4.6M as of Q2 2026.
  • Jefferies Financial Group bought 30,760 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.09M.
  • Mirum Pharmaceuticals made up 0.03% of Jefferies Financial Group's portfolio in Q2 2026, its #402 holding.
  • Jefferies Financial Group first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.